Inventor · disambiguated record
Samuel Gerritz
Also filed as: GERRITZ SAMUEL · GERRITZ SAMUEL W
20 granted patents·11 pending applications·131 citations·filing 2004–2023
94Inventor score
Files withBRISTOL MYERS SQUIBB CO15HALDA THERAPEUTICS OPCO INC6WANG TAO3SUN CHONGQING2BALDWIN ERIC T1
Top patents by PatentIndex Score
31 records- 0192US8445490B2Compounds for the treatment of hepatitis CWANG TAO·Filed 2011·Granted May 21, 2013·11 cites·2 claims
- 0291US7884113B2Tetrahydroquinoline derivatives as cannabinoid receptor modulatorsBRISTOL MYERS SQUIBB CO·Filed 2008·Granted Feb 8, 2011·8 cites·8 claims
- 0391US7517900B2Pyrazole derivatives as cannabinoid receptor modulatorsBRISTOL MYERS SQUIBB CO·Filed 2004·Granted Apr 14, 2009·28 cites·32 claims
- 0490US8119808B2Tetrahydroquinoline derivatives as cannabinoid receptor modulatorsSUN CHONGQING·Filed 2011·Granted Feb 21, 2012·8 cites·9 claims
- 0584US7378418B2Azabicyclic heterocycles as cannabinoid receptor modulatorsBRISTOL MYERS SQUIBB CO·Filed 2004·Granted May 27, 2008·24 cites·31 claims
- 0684US7273882B2Aminoacetamide acyl guanidines as β-secretase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2006·Granted Sep 25, 2007·7 cites·7 claims
- 0783US8586584B2Compounds for the treatment of hepatitis CWANG TAO·Filed 2010·Granted Nov 19, 2013·7 cites·15 claims
- 0883US7390925B2Oxime-containing acyl guanidines as beta-secretase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2007·Granted Jun 24, 2008·5 cites·9 claims
- 0983US7214804B2Heterocyclic compounds useful as growth hormone secretagoguesBRISTOL MYERS SQUIBB CO·Filed 2005·Granted May 8, 2007·11 cites·5 claims
- 1082US8633200B2Inhibitors of human immunodeficiency virus replicationPENDRI ANNAPURNA·Filed 2011·Granted Jan 21, 2014·5 cites·13 claims
- 1182US7408071B2N-aryl pyrrolidine derivatives as beta-secretase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2007·Granted Aug 5, 2008·4 cites·7 claims
- 1278US8741884B2Compounds for the treatment of hepatitis CWANG TAO·Filed 2011·Granted Jun 3, 2014·4 cites·15 claims
- 1376US9034882B2Inhibitors of human immunodeficiency virus replicationBRISTOL MYERS SQUIBB CO·Filed 2013·Granted May 19, 2015·3 cites·14 claims
- 1473US8865708B2Methods and compositions for inhibition of the transitional endoplasmic reticulum ATPaseDESHAIES RAYMOND J·Filed 2011·Granted Oct 21, 2014·2 cites·18 claims
- 1572US7709647B2Tetrahydroquinoline cannabinoid receptor modulatorsBRISTOL MYERS SQUIBB CO·Filed 2008·Granted May 4, 2010·1 cites·2 claims
- 1666US8362004B2Piperazine analogs as broad-spectrum influenza antiviralsBRISTOL MYERS SQUIBB CO·Filed 2011·Granted Jan 29, 2013·1 cites·28 claims
- 1765US7816357B2Azabicyclic heterocycles as cannabinoid receptor modulatorsBRISTOL MYERS SQUIBB CO·Filed 2004·Granted Oct 19, 2010·2 cites·24 claims
- 1855US7678784B2Oxime-containing macrocyclic acyl guanidines as β-secretase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2007·Granted Mar 16, 2010·0 cites·8 claims
- 1954US7732434B2Macrocyclic acyl guanidines as beta-secretase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2008·Granted Jun 8, 2010·0 cites·5 claims
- 2052US2025388575A1Heterobifunctional compounds and methods of treating diseaseHALDA THERAPEUTICS OPCO INC·Filed 2023·Application pending·0 cites
- 2152US2024238424A1Heterobifunctional compounds and methods of treating diseaseHALDA THERAPEUTICS OPCO INC·Filed 2023·Application pending·0 cites
- 2252US2025388605A1Heterobifunctional compounds and methods of treating diseaseHALDA THERAPEUTICS OPCO INC·Filed 2023·Application pending·0 cites
- 2350US2025032623A1Heterobifunctional compounds and their use in treating diseaseHALDA THERAPEUTICS OPCO INC·Filed 2022·Application pending·0 cites
- 2450US2025136619A1Heterobifunctional compounds and their use in treating diseaseHALDA THERAPEUTICS OPCO INC·Filed 2022·Application pending·0 cites
- 2549US2006160850A1Bicyclic heterocycles as cannabinoid receptor modulatorsSUN CHONGQING·Filed 2006·Application pending·0 cites
- 2649US2020268897A1Phosphatase Binding Compounds and Methods of Using SameUNIV YALE·Filed 2020·Application pending·0 cites
- 2747US7612069B2Acyl guanidines as beta-secretase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2006·Granted Nov 3, 2009·0 cites·11 claims
- 2847US2024408093A1Heterobifunctional compounds and their use in treating diseaseHALDA THERAPEUTICS OPCO INC·Filed 2022·Application pending·0 cites
- 2937US2014011700A1Three-dimensional structure of h1n1 nucleoprotein in complex with antiviral compoundsBALDWIN ERIC T·Filed 2012·Application pending·0 cites
- 3036US2012245176A1Novel piperazine analogs with substituted heteroaryl groups as broad-spectrum influenza antiviralsCIANCI CHRISTOPHER W·Filed 2011·Application pending·0 cites
- 3136US2017370929A1Positive allosteric modulators of the delta-opioid receptorBRISTOL MYERS SQUIBB CO·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Samuel Gerritz files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →